The International Society for Stem Cell Application (ISSCA) – a Global Stem Cells Group (GSCG) division – is thrilled to announce its upcoming Conference on Regenerative Medicine and Cellular Therapies in Buenos Aires, Argentina.
The conference is scheduled at the Marriott Hotel on June 3-4, 2023. This spectacular event offers scientists and medical professionals an excellent opportunity to broaden their knowledge of regenerative medicine. Attendees will learn about the latest clinical applications of stem cell therapies from elite speakers, including scientists and physicians with extensive experience in the field.
Highlights of the Conference
Hear from Professionals
The event offers an all-inclusive program featuring hands-on certification, workshops, and theoretical lectures. Attendees will have the opportunity to communicate with like-minded experts from all walks of life and become part of an evolving community leading the future of medicine.
An Opportunity to Network
Medical practitioners and stakeholders can learn from experts in the industry through this leading international program. All stakeholders and practitioners are welcome to attend the event. These include:
● Doctors, Researchers & Innovators.
● Decision-makers and funding agencies.
● Experts seeking collaborative work on stem cell technology.
● Professional bodies.
● Marketing professionals.
Hands-On and One-On-One Training by Experienced Instructors
The conference will feature hands-on and one-on-one training sessions with professional, ISSCA-certified instructors. Attendees will get intensive hands-on experience with stem cell therapy’s aesthetic and clinical application. The event will last for two days, with one day set apart for lectures and two days for hands-on certification from professionals in the field. ISSCA will give attendees a certificate of completion upon program completion.
Knowledge of a Wide Range of Topics in Stem Cell Research
A panel of esteemed experts on stem cells and regenerative medicine will feature at the conference. They will conduct a one-day rigorous research-based discussion on the vital topic covering stem cells and regenerative medicine.
The conference will focus on a wide range of topics, including:
● Updates in stem cell research.
● Clinical applications of cellular therapies and regenerative medicine.
● The modern methods of harvest and isolation.
● Non-invasive surgical guidelines.
● Regenerative medicine and tissue engineering.
● Techniques for the effective delivery of cell products.
● Regulatory and ethical challenges in stem cell technology.
● Modern technologies to enhance marketing and networking.
The attendees of the conference will be treated to a gala dinner that includes a gourmet wine tasting at the Marriot Hotel at the conclusion of the first day’s proceedings. On June 4, the second day of the event, Dr. Silvina Pastrana and Dr. Andrea Lapeire, both certified ISSCA mentors hailing from Argentina, will be conducting an extensive hands-on training session on the clinical and aesthetic applications of stem cell therapy.
For science and medical professionals seeking to advance their skills and knowledge in regenerative medicine, the ISSCA Conference on Regenerative Medicine and Cellular Therapies is a must-attend event. Attendees will acquire knowledge and access to diverse brands, products, and technologies for stem cell therapy.
For attendees, one of the main advantages of attending the conference is the opportunity to learn about the following:
● Latest technologies.
● Products and equipment for stem cell therapy.
● Tissue engineering.
● Regenerative medicine in general.
ISSCA is delighted to announce an impressive lineup of renowned speakers for its upcoming event, including:
● Dr. Salih Yildirim, ISSCA Overseas Director from Turkey
● Benito Novas, Managing Director of Global Stem Cells Group and Head of Public Relations for the International Society for Stem Cell Application from the USA
● Dr. Silvina Pastrana and Dr. Andrea Lapeire from Argentina
● Dr. Melihcan Sezgic from Turkey
● Dr. Julian Petrolito, Prof. Dr. Julio Ferreira, Dr. Pedro Celeri, Dr. Florencia Leinado, Dr. Hernan Diego Iriarte, Dr. Alejandro Guala, Dr. Afonso Ciancagili, and Dr. Jorge Elias, all from Argentina
● Dr. Roni Moya from Portugal
● Dr. Ramon Antonio Saldaña from Dominican Republic
To learn more about the ISSCA Buenos Aires, Argentina conference and to make a reservation, visit the https://www.issca.us/issca-world-conferences/ website, email firstname.lastname@example.org, or call +1305 560 5337.
The International Society for Stem Cell Application (ISSCA) is a multidisciplinary community of scientists and physicians who aspire to treat diseases and lessen human suffering through advances in science, technology, and regenerative medicine.
ISSCA updates its members on advances in stem cell research, MSC, exosomes, and regenerative medicine
The ISSCA’s vision is to take a leadership position in promoting excellence and setting standards in the regenerative medicine fields of publication, research, education, training, and certification.
The international community provides a platform for practitioners to interact with scientists and build medical networks necessary for marketing.
As a medical specialty, regenerative medicine standards and certifications are essential, which is why ISSCA offers certification training in cities worldwide. The goal is to encourage more physicians to practice regenerative medicine and make it available to patients nationally and internationally. Incorporated under the Republic of Korea as a non-profit company, the ISSCA is focused on fostering excellence and standards in regenerative medicine.
About Global Stem Cells Group
Global Stem Cells Group is the parent company of six companies that are dedicated to stem cell research, solutions, and technology training. The group was founded in 2012 and combines dedicated researchers, patient educators, and physician trainers with the shared goal of meeting the need for high-end stem cell solutions and treatments.
Given that the group has a singular focus in this field, it is uniquely positioned to become the global leader in cellular medicine. In addition, by bringing together leading professionals in cellular medicine, it can discover issues that the industry faces and focus its research and development in this area. This specialization has, undoubtedly, enabled it to come up with solutions that address some of the significant issues that most stakeholders are facing in the industry.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
Safe Harbor Statement: Statements in this news release may be “forward-looking statements”. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and The Global Stem Cells Group undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release. This press release does not constitute a public offer of any securities for sale. Any securities offered privately will not be or have not been registered under the Act and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.